Literature DB >> 24084010

Organ donation as transition work: Policy discourse and clinical practice in The Netherlands.

Katharina T Paul1, Cees J J Avezaat2, Jan N Ijzermans2, Roland D Friele3, Roland A Bal4.   

Abstract

An increasing number of patients become eligible for organ transplants. In the Netherlands, at the level of policy discourse, growing waiting lists are often referred to as a persistent "shortage" of organs, producing a "public health crisis." In this way, organ donation is presented as an ethical, social, and medical necessity. Likewise, policy discourse offers a range of seemingly unambiguous solutions: improving logistical infrastructure at the level of hospitals, developing organizational and legal protocols, as well as public information campaigns. Instead of taking these problem and solution definitions as given, we critically examine the relationship between policy discourse and clinical practice. Based on a historical review, first, we trace the key moments of transformation where organ donation became naturalized in Dutch policy discourse, particularly in its altruistic connotation. Second, based on in-depth interviews with medical professionals, we show how those involved in organ donation continue to struggle with the controversial nature of their clinical practice. More specifically, we highlight their use of different forms of knowledge that underlie clinicians' "transition work": from losing a patient to "gaining" a donor.
© The Author(s) 2013.

Entities:  

Keywords:  death dying and bereavement; health policy; profession and professionalization; research methodology; technology in health care

Mesh:

Year:  2013        PMID: 24084010     DOI: 10.1177/1363459313501357

Source DB:  PubMed          Journal:  Health (London)        ISSN: 1363-4593


  1 in total

1.  [Assessment of the transplantation scandal by the media : scientific discourse analysis of selected German newspapers].

Authors:  A Hoisl; R Barbey; B M Graf; J Briegel; T Bein
Journal:  Anaesthesist       Date:  2014-12-13       Impact factor: 1.041

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.